| Spirig HealthCare AG - Esomeprazol Spirig HC 40 mg, magensaftresistente Tabletten | | 65828 | | 02 | | Esomeprazol Spirig HC 40 mg | | magensaftresistente Tabletten | | A02BC05 | | Esomeprazol | | 14.07.2015 | | |
| | Composition | | esomeprazolum 40 mg ut esomeprazolum magnesicum dihydricum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, natrii laurilsulfas, talcum, triethylis citras, hypromellosum, sacchari sphaerae corresp. saccharum 9.46 mg et maydis amylum, magnesii stearas, hydroxypropylcellulosum, glyceroli monostearas 40-55, polysorbatum 80, cellulosum microcristallinum, povidonum K 29-32, macrogolum 6000, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), E 172 (flavum), pro compresso obducto corresp. natrium 0.03 mg. | | Packungsbestandteile | | Comprimés résistants au suc gastrique | | | | | Principe actif | Concentr. |
|---|
| Esomeprazol | 40 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Esomeprazol | 40 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Acidi Methacrylici | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Ethylis Acrylatis Polymerisatum Dispersio | 30 | | | Glyceroli Monostearas | 40-55 | | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Maydis Amylum | | | | Natrii Laurilsulfas | | | | Natrii Stearylis Fumaras | | | | Per Centum | | | | Polysorbatum 80 | | | | Povidonum K | 29-32 | | | Pro Compresso Obducto | | | | Sacchari Sphaerae | | | | Talcum | | | | Triethylis Citras | | |
| |
| |
|
